| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +530,038 | 46% | $37.71 | +$19,988,986 |
| Sells | 15 | -612,677 | 54% | $38.27 | -$23,444,887 |
| Net | -14 | -82,639 | -7.2% | -$3,455,901 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Invus Public Equities, L.P. | 10%+ Owner | $385,262,708 | 10 Dec 2024 | ||
| Samsara BioCapital GP, LLC | 10%+ Owner | $108,133,716 | 16 Oct 2023 | ||
| Siren, L.L.C. | 10%+ Owner | $101,166,050 | 25 Jul 2024 | ||
| Kristina Burow | Director | $74,283,952 | -$160,511 | -0.22% | 29 May 2025 |
| SRINIVAS AKKARAJU | Director | $69,429,463 | +$19,988,986 | +40% | 07 Oct 2025 |
| David Hallal | Chief Executive Officer, Director | $67,193,879 | 08 Oct 2025 | ||
| Vikas Sinha | Chief Financial Officer | $19,290,000 | 02 May 2025 | ||
| Keith Woods | Chief Operating Officer | $19,290,000 | 02 May 2025 | ||
| Akshay Vaishnaw | President of R&D, Director | $18,490,586 | -$200,612 | -1.1% | 29 May 2025 |
| Jay T. Backstrom | CHIEF EXECUTIVE OFFICER, Director | $16,062,247 | -$1,662,574 | -9.4% | 10 Mar 2025 |
| Nagesh K. Mahanthappa | Interim CEO and President | $7,653,597 | 16 Jun 2022 | ||
| Junlin Ho | General Counsel | $7,122,519 | -$849,125 | -11% | 16 Jun 2025 |
| Mo Qatanani | Chief Scientific Officer | $4,926,534 | -$10,364,924 | -68% | 04 Dec 2025 |
| Caryn Parlavecchio | Chro | $4,845,237 | -$745,252 | -13% | 18 Aug 2025 |
| YUNG H. CHYUNG | Chief Medical Officer | $4,117,505 | 14 Feb 2022 | ||
| Edward H. Myles | Coo & Cfo | $3,882,600 | -$5,910,761 | -60% | 10 Mar 2025 |
| Jing L. Marantz | Chief Medical Officer | $3,830,419 | -$249,935 | -6.1% | 10 Mar 2025 |
| Erin Moore | Interim PFO and PAO | $2,735,994 | -$449,237 | -14% | 24 Mar 2025 |
| Tracey Sacco | Chief Commercial Officer | $2,402,548 | -$551,072 | -19% | 25 Apr 2025 |
| Gregory John Carven | Chief Scientific Officer | $2,042,187 | 16 Jun 2022 | ||
| Michael Gilman | Director | $1,647,341 | -$100,304 | -5.7% | 29 May 2025 |
| Katie Peng | Director | $1,468,828 | -$208,593 | -12% | 16 Dec 2025 |
| JEFFREY S. FLIER | Director | $755,798 | -$1,650,994 | -69% | 16 Jul 2025 |
| Amir Nashat | Director | $608,302 | 09 May 2024 | ||
| Joshua Reed | Director | $472,644 | -$160,463 | -25% | 29 May 2025 |
| Richard Brudnick | Director | $451,756 | -$180,531 | -29% | 29 May 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|